BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8540338)

  • 1. Comparison of biochemical properties of natural and recombinant cathepsin E.
    Tsukuba T; Masayuki Y; Hori H; Azuma T; Yamamoto K
    Adv Exp Med Biol; 1995; 362():331-4. PubMed ID: 8540338
    [No Abstract]   [Full Text] [Related]  

  • 2. Cathepsin E and cathepsin D: biosynthesis, processing and subcellular location.
    Yamamoto K
    Adv Exp Med Biol; 1995; 362():223-9. PubMed ID: 8540322
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human cathepsin E.
    Hill J; Montgomery D; Kay J
    Adv Exp Med Biol; 1995; 362():315-8. PubMed ID: 8540334
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical properties of the monomeric mutant of human cathepsin E expressed in Chinese hamster ovary cells: comparison with dimeric forms of the natural and recombinant cathepsin E.
    Tsukuba T; Sakai H; Yamada M; Maeda H; Hori H; Azuma T; Akamine A; Yamamoto K
    J Biochem; 1996 Jan; 119(1):126-34. PubMed ID: 8907186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of recombinant human cathepsin E expressed in Chinese hamster ovary cells.
    Tsukuba T; Hori H; Azuma T; Takahashi T; Taggart RT; Akamine A; Ezaki M; Nakanishi H; Sakai H; Yamamoto K
    J Biol Chem; 1993 Apr; 268(10):7276-82. PubMed ID: 8463263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and intracellular distribution of cathepsins E and D in differentiating murine Friend erythroleukemia cells.
    Sakai H; Kato Y; Yamamoto K
    Arch Biochem Biophys; 1992 May; 294(2):412-7. PubMed ID: 1567196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization and targeting of cathepsin E.
    Finley EM; Kornfeld S
    J Biol Chem; 1994 Dec; 269(49):31259-66. PubMed ID: 7983070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease.
    Mackay EA; Ehrhard A; Moniatte M; Guenet C; Tardif C; Tarnus C; Sorokine O; Heintzelmann B; Nay C; Remy JM; Higaki J; Van Dorsselaer A; Wagner J; Danzin C; Mamont P
    Eur J Biochem; 1997 Mar; 244(2):414-25. PubMed ID: 9119007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin E.
    Jupp RA; Richards AD; Kay J; Dunn BM; Wyckoff JB; Samloff IM; Yamamoto K
    Biochem J; 1988 Sep; 254(3):895-8. PubMed ID: 3058118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of recombinant human cathepsin E.
    Iida H; Matsuba T; Yamada M; Azuma T; Suzuki H; Yamamoto K; Hori H
    Adv Exp Med Biol; 1995; 362():325-30. PubMed ID: 8540336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the binding preferences/specificity in the active site of human cathepsin E.
    Rao-Naik C; Guruprasad K; Batley B; Rapundalo S; Hill J; Blundell T; Kay J; Dunn BM
    Proteins; 1995 Jun; 22(2):168-81. PubMed ID: 7567964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation and immunohistochemical localization of cathepsins E and D in rat tissues and blood cells.
    Sakai H; Saku T; Kato Y; Yamamoto K
    Biochim Biophys Acta; 1989 May; 991(2):367-75. PubMed ID: 2655714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293.
    Cappiello MG; Wu Z; Scott BB; McGeehan GM; Harrison RK
    Protein Expr Purif; 2004 Sep; 37(1):53-60. PubMed ID: 15294281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular localization of engineered proteoglycans.
    Chen TL; Wang P; Gwon SS; Flay NW; Vertel BM
    Methods Mol Biol; 2001; 171():301-8. PubMed ID: 11450241
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the specificity of the aspartic proteinases towards internally consistent sets of oligopeptide substrates.
    Dunn BM; Oda K; Kay J; Rao-Naik C; Lowther WT; Beyer BM; Scarborough PE; Bukhtiyarova M
    Adv Exp Med Biol; 1998; 436():133-8. PubMed ID: 9561210
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological significance and activity control of cathepsin E compared with cathepsin D.
    Yamamoto K; Sakai H; Ueno E; Kato Y
    Adv Exp Med Biol; 1991; 306():297-306. PubMed ID: 1812720
    [No Abstract]   [Full Text] [Related]  

  • 17. Procathepsin E and cathepsin E.
    Kageyama T
    Methods Enzymol; 1995; 248():120-36. PubMed ID: 7545776
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant human cathepsin H lacking the mini chain is an endopeptidase.
    Vasiljeva O; Dolinar M; Turk V; Turk B
    Biochemistry; 2003 Nov; 42(46):13522-8. PubMed ID: 14621998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin X binds to cell surface heparan sulfate proteoglycans.
    Nascimento FD; Rizzi CC; Nantes IL; Stefe I; Turk B; Carmona AK; Nader HB; Juliano L; Tersariol IL
    Arch Biochem Biophys; 2005 Apr; 436(2):323-32. PubMed ID: 15797245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of human endothelin by cathepsin E.
    Lees WE; Kalinka S; Meech J; Capper SJ; Cook ND; Kay J
    FEBS Lett; 1990 Oct; 273(1-2):99-102. PubMed ID: 2226872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.